 | This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (July 2024) |
| Abbreviation | NSABB |
|---|---|
| Location | |
Membership | Jason Boehm (Department of Commerce) David Christian Hassell (Department of Defense) Sharlene Weatherwax (Department of Energy) Anthony S. Fauci (Department of Health and Human Services) Sally Phillips (Department of Health and Human Services) CAPT Carmen Maher (Department of Health and Human Services) Michael W. Shaw(Department of Health and Human Services) |
The National Science Advisory Board for Biosecurity (NSABB) is a panel of experts that reports to the Secretary of the United States Department of Health and Human Services. It is tasked with recommending policies on such questions as how to prevent published research in biotechnology from aiding terrorism, without slowing scientific progress.[1]
The NSABB is a federal advisory committee that addresses issues related to biosecurity and dual use research at the request of the United States Government. The NSABB has up to 25 voting members with a broad range of expertise including molecular biology, microbiology, infectious diseases, biosafety, public health, veterinary medicine, plant health, national security, biodefense, law enforcement, scientific publishing, and other related fields.[2]
- ^ "National Science Advisory Board for Biosecurity (NSABB)". Office of Science Policy. Retrieved 2022-02-16.
- ^ "National Science Advisory Board for Biosecurity (NSABB)". National Institutes of Health. Office of Science Policy. Retrieved 4 February 2021.